Publications by authors named "Dinesh Dhanya"
Objectives: The role of lymphadenectomy in the management of early endometrial cancer remains controversial. The aim of our study was to evaluate risk factors associated with nodal metastases in endometrial cancer and to devise a predictive risk model based on the significant risk factors in predicting node metastasis.
Materials And Methods: A retrospective study was conducted on women diagnosed with uterus-confined endometrial cancer, and who underwent surgical staging with pelvic and/or paraaortic lymphadenectomy from our center during July 1, 2017 to June 30, 2019.
Clinical Profile and Survival Outcome of Endometrial Cancer with p53 Mutation.
Indian J Surg Oncol
September 2022
Clinicopathologic classification of endometrial cancer imperfectly reflects the tumor biology. Pathologic categorization - especially in high-grade tumors - results in an imprecise estimation of the risk of disease, recurrence, and death. Molecular subtyping is emerging as the standard of care in diagnosis and treatment of endometrial cancers.
View Article and Find Full Text PDFArticle Synopsis
- - Ovarian cysts can sometimes be linked to endocrine disorders, with hypothyroidism being a rare cause that may mimic cancer.
- - The report discusses three cases of patients mistakenly suspected of having ovarian cancer, but they were actually found to have severe hypothyroidism.
- - After starting treatment with thyroxine, the patients experienced significant improvement and their ovarian masses resolved, highlighting the importance of considering hypothyroidism in similar cases to prevent unnecessary surgeries.
Background: Cervical intraepithelial neoplasia (CIN) is the precursor lesion of cervical cancer. Untreated high-grade CIN significantly increases the risk of developing invasive cancer. Conization is the main treatment.
View Article and Find Full Text PDFPerivascular Epithelioid Cell Tumour of the Uterus: a Case Report.
Indian J Surg Oncol
September 2020
Objective: To assess the feasibility of gallium 68 (Ga)-prostate specific membrane antigen (PSMA) PET/computed tomography (CT) to identify patients who truly harbor clinically significant prostate cancer (PCa) in a cohort of patients with clinical and biochemical/radiological suspicion of PCa.
Patients And Methods: A total of 118 patients with suspected PCa who underwent Ga-PSMA PET/CT between May 2015 and June 2016 were prospectively included. Final decision on performing biopsy was left to the referring urologist after considering the clinical data, scan findings and discussion with the patient.